[Effect of growth hormone supplementation on liver and lung function in patients with hypopituitarism].
Zhonghua Yi Xue Za Zhi
; 104(6): 450-452, 2024 Feb 06.
Article
en Zh
| MEDLINE
| ID: mdl-38326058
ABSTRACT
To analyze the clinical features of patients with anterior hypopituitarism (HP) complicated with cirrhosis, and to explore the effects of growth hormone supplementation on liver and lung function. A total of 11 patients with HP complicated with cirrhosis admitted to Peking Union Medical College Hospital from January 2016 to December 2022 were included in the study, including 8 males and 3 females, aged [M(Q1, Q3)]31 (20, 37) years. There were 6 patients with pituitary stalk interruption syndrome, 4 patients after craniopharyngioma resection, and 1 patient after germinal cell tumor chemoradiotherapy. Cirrhosis appeared at [M(Q1, Q3)]7 (1, 16) years after the diagnosis of HP. There were 7 cases complicated with hepatopulmonary syndrome (HPS). The liver and lung function of 5 patients were improved significantly after the addition of growth hormone, and the arterial partial pressure of oxygen increased from (47±11) mmHg(1 mmHg=0.133 kPa) to (84±12) mmHg. Timely supplementation of growth hormone can improve the symptoms of fatty liver, cirrhosis and HPS, and postpone or even avoid the transplantation of liver and other organs.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Hipofisarias
/
Hormona de Crecimiento Humana
/
Síndrome Hepatopulmonar
/
Hipopituitarismo
Tipo de estudio:
Diagnostic_studies
Idioma:
Zh
Revista:
Zhonghua Yi Xue Za Zhi
Año:
2024
Tipo del documento:
Article
País de afiliación:
China